Research Institute Goes Red for Heart Health

Every February at MedStar Health Research Institute, we celebrate “Heart Healthy” and take the time to “Go Red!” for heart health. Associates were invited to wear red in support of the American Heart Association’s (AHA) fight against heart disease in February. Throughout the month, associates submitted photos with their teams to show their commitment to heart health. 

As we have for the last nine years, we accepted submissions for a photo challenge! Associates showed off in their red outfits and team spirit to show their commitment to heart health. View all the photo submissions from Research Institute teams below. 

Thank you to all who showed their support for this important cause!

 

 

 

 

COVID-19 Community Research Partnership: MedStar Health Data

Thank you to all current participants in the study! Below you will find some data about the current survey results.

 

Contact Information

Contact us to obtain more information about our research programs.

COVID-19 Community Research Partnership FAQs

Thank you for your interest in learning more about this study. Please read the following information to ensure that you would like to participate. Then click the link below to get started.

Researchers at MedStar Health are partnering with patients to better understand the spread of COVID-19. Study participants will answer short online questions (that take less than 30 seconds a day) over several months about possible exposures, symptoms and health care visits. Some volunteers may be asked to complete an in-home test kit for antibodies to COVID-19.

This study is open to everyone in our community, whether or not you have received care at MedStar Health.

I would like to enroll in this study.

Contact Information

Contact us to obtain more information about our research programs.

Search Principal Investigators

If you would like to learn more about MedStar's researchers and scientists, please visit our Principal Investigator search portal.

Asociación de investigación comunitaria de COVID-19

Gracias por su interés en aprender más sobre este estudio. Por favor, lea la siguiente información para asegurarse de que desea participar. Luego, haga clic en el siguiente enlace para empezar.

Los investigadores de MedStar Health se están asociando con los pacientes para comprender mejor la propagación del COVID-19. Los participantes del estudio responderán a breves preguntas en línea (que tarda menos de 30 segundos al día) durante varios meses sobre posibles exposiciones, síntomas y visitas de atención médica. A algunos voluntarios se les puede pedir que completen un kit de prueba casera para detectar anticuerpos contra COVID-19.

Cualquier persona mayor de 18 años puede participar en este estudio. No es necesario que tenga síntomas o COVID-19.

Me gustaria inscribirme en este estudio.

Las preguntas sobre este estudio de investigación pueden ser respondidas llamando al 800-808-5759 o enviando un correo electrónico a la Asociación de investigación comunitaria de COVID-19 a [email protected].

Los estudios de investigación están diseñados para obtener conocimientos científicos que puedan ayudar a las personas en el futuro.

Por favor, tómese su tiempo para decidir si desea participar o no en este estudio de investigación. También puede discutir este estudio y su decisión de participar con sus amigos y familiares. Si tiene preguntas sobre el estudio, llame al 800-808-5759 o envié un correo electrónico a la Asociación de investigación comunitaria de COVID-19 a [email protected].

Vea los datos actualizados de los participantes de la Asociación de investigación comunitaria de COVID-19.

Cualquier persona mayor de 18 años puede participar en este estudio. No es necesario que tenga síntomas o COVID-19.

Primero debe leer el consentimiento de informacion y proporcionará su firma electrónica.

El consentimiento de informacion es importante porque:

  • Describe el estudio
  • Explica por qué se está realizando el estudio
  • Describe lo que se espera de usted
  • Describe los riesgos y beneficios de participar
  • Explica cómo ponerse en contacto con el equipo del estudio si tiene alguna pregunta

Si usted lee el consentimiento informado y decide que no quiere participar en el estudio, está bien. Por favor, no firme el formulario de consentimiento si no quiere participar.

Como usted sabe, la pandemia del COVID-19 es una emergencia mundial de salud pública.

Al estudiar quién ha sido expuesto(a) y posiblemente infectado(a), identificar el momento y las circunstancias de la exposición, y dónde los patrones de infección del COVID-19 están avanzando, los investigadores pueden ayudar a la comunidad médica a entender mejor la pandemia y desarrollar estrategias y tratamientos para contenerla y posiblemente eliminarla.

El objetivo de este estudio es recopilar información sobre las exposiciones a COVID-19 en la comunidad, los síntomas y las visitas de atención médica debidas a la enfermedad. Si usted es del personal de salud, el estudio recopilará información sobre el uso que haga de su equipo de protección personal.

La participación no tiene costo alguno.

La información recopilada sobre usted es solo para fines de investigación. Esta información no se utilizará para guiar su atención médica. Su medico o proveedor de atención médica no tendrá acceso a esta información.

El estudio de investigación no puede proporcionar atención médica o pruebas de COVID-19 si usted se enferma. Los cuestionarios y las pruebas caseras son solo para fines de investigación.

Después de completar el consentimiento informado en línea, se le pedirá que complete un breve cuestionario de inscripción.

Recibirá un correo electrónico con un enlace para completar un formulario de registro en línea. El formulario puede ser completado en su teléfono inteligente, tableta o computadora.

Periódicamente, durante un año, recibirá un enlace a un cuestionario muy breve para completar.

Tarda menos de 30 segundos en completarse y puede responder a las preguntas en su teléfono inteligente, tableta o computadora. Inicialmente, recibirá el cuestionario todos los días. Con el tiempo puede recibirlo con menos frecuencia. El estudio continuará mientras existan inquietudes sobre la pandemia en nuestra región; sin embargo, usted puede dejar de recibir los cuestionarios en cualquier momento.

El cuestionario cubrirá lo siguiente:

  • Su historial o síntomas de la enfermedad de COVID-19
  • Sus visitas al médico y tratamientos
  • Su contacto con otras personas enfermas
  • Si usted es del personal de salud, información sobre el uso que haga de su equipo de protección personal

La información recopilada en el cuestionario se utilizará para fines de investigación y no se incluirá en sus registros médicos.

A algunos participantes también se les puede pedir que completen un kit de prueba en el hogar para detectar anticuerpos contra SARS-CoV-2 (el virus que causa el COVID-19). Usted puede decidir solo completar cuestionarios o puede agregar la prueba casera a su participación.

En esta parte, se le puede pedir que realice pruebas caseras mensuales que detecten anticuerpos contra el virus. La prueba casera requiere de un pinchazo para recolectar una muestra de su sangre en una barra de prueba. El kit le indicará que:

  • Tome una fotografía de la barra de prueba y envíela mediante una aplicación de su teléfono inteligente; o
  • Empaque la barra de prueba en uno de los sobres de devolución adjunto y envíelo atreves del servicio postal de los Estados Unidos.

La prueba casera no diagnostica COVID-19. Las pruebas se realizan únicamente con fines de investigación.

Las preguntas sobre este estudio de investigación pueden ser respondidas llamando al 800-808-5759 o enviando un correo electrónico a la Asociación de investigación comunitaria de COVID-19 a [email protected].

Empezar

Me gustaria inscribirme en este estudio.






COVID-19 Community Research Partnership

Thank you for your interest in learning more about this study. Please read the following information to learn more about the study and what you will be asked to do if you choose to participate. When you finish reading this information, there will be a link at the end on how to sign up for the study.

Researchers at MedStar Health are partnering with patients to better understand the spread of COVID-19 in our communities. Study participants will answer short online questions (that take less than 30 seconds a day) over the next year about possible exposure to the virus, symptoms, and health care visits. Some volunteers may be asked to complete an in-home test kit for antibodies to COVID-19.

This study is part of a nation-wide research project. You can find more frequently asked questions (FAQs) on the study website here.

Anyone in our community can take part in the study, whether or not you have received care at a MedStar Health clinic or Hospital.

.

I would like to participate in this study.

Join the Fight Against COVID-19 with MedStar Health!

Get answers to any questions you have about this research study by calling 800-808-5759 or emailing COVID-19 Community Research Partnership at [email protected].

Research studies are a way to gain scientific knowledge that may help people in the future.

Please take your time deciding whether or not you wish to participate in this research study. You may also discuss this study and your decision to participate with your friends and family. If you have questions about the study please call 800-808-5759 or email the COVID-19 Community Research Partnership at [email protected].

Anyone over the age of 18 can participate in this study. You do not need to have symptoms or COVID-19.

Yes! Anyone can take part in the study no matter where you live. If you are not a MedStar Health patient, we will not have access to your medical records, but we can still learn a lot from your participation. The information you share with us will be help us understand how our community as a whole is being affected by COVID-19.

No. If you are a MedStar Health patient, you can give us permission to access your medical records. Your medical records will remain confidential and be securely stored by the study team. Your information will be used only when mixed with other participant records. The study team will not be reviewing your individual records for this study.

If you are not a MedStar Health patient, we will not be able to link your data to your medical records. We will not contact your doctor or access your medical records in any way. But, we can still learn a lot from your participation. The information you share with us will still be valuable to help us understand how our community as a whole is being affected by COVID-19.

The information collected about you is for research purposes only. This information will not be used to guide your medical care. Your doctor or health care provider will not have access to this information. We will only be using your information in collection with other participants which will protect your privacy.

If you are eligible to participate, you will first read the informed consent and provide your electronic signature.

Informed consent is important because it:

  • Describes the study
  • Explains why the study is being done
  • Describes what is expected from you
  • Describes the risks and benefits of taking part
  • Explains how to contact the study team with questions

If you read the informed consent document and decide that you don’t want to participate in the study, that’s OK. Please do not sign the consent form if you don’t want to participate.

As you are aware, the COVID-19 pandemic is a global public health emergency.

By studying who has been exposed and possibly infected, better identifying the timing and circumstances of exposure, and where infection patterns of the COVID-19 are progressing, researchers can help the medical community better understand the pandemic and develop strategies and treatments to contain and possibly eliminate it.

The goal of this study is to collect information about the community’s COVID-19 exposures, symptoms, and health care visits due to the disease. If you are a health care worker, the study will collect information on your use of personal protective equipment.

There is no cost for participating.

The information collected about you is for research purposes only. This information will not be used to guide your medical care. Your doctor or health care provider will not have access to this information.

The research study cannot provide medical care or COVID-19 testing if you become sick. The questionnaires and at-home testing is for research purposes only. The daily symptom tracker and test results are not meant to diagnose or treat anyone for COVID-19.

After completion of the online informed consent, you will be asked to complete a brief enrollment questionnaire.

You will receive an email with a link to complete an online registration form. The form can be completed on your smartphone, tablet or computer.

Daily, for up to one year, you will receive a link to a very brief questionnaire to complete.

It takes less than 30 seconds to complete, and you can answer the questions on your smartphone, tablet or computer. Initially, you will receive the questionnaire every day. Over time you may receive it less often. The study will continue as long as there are concerns about the pandemic in our region; however, you can stop receiving the questionnaires at any time.

The questionnaire will cover the following:

  • Your COVID-19 illness history or symptoms
  • Your visits to the doctor and treatments
  • Your contact with other sick people
  • If you are a health care worker, your use of personal protective equipment

The information collected in the questionnaire will be used for research purposes and will not be entered into your medical records.

Some participants may also be asked to complete an in-home test kit for antibodies to SARS-CoV-2 (the virus that causes COVID-19). You can decide to only complete questionnaires or you can add the at-home testing to your participation.

For this part of the study you may be asked to complete monthly at-home tests which detect antibodies to the virus. At-home testing requires a finger prick for collecting a sample of your blood on a stick. Your kit will instruct you to either:

  • Take a picture of the test stick and send the picture using an app on your smart phone; or
  • Package the test stick in an enclosed return mailer and put into the US mail.

The at-home testing does not diagnose COVID-19. Testing is for research purposes only.

Questions on this research study can be answered by calling 800-808-5759 or emailing the COVID-19 Community Research Partnership at [email protected].

I would like to participate in this study.






Seeking Potential Plasma Donors Who Had COVID-19 and are Fully Recovered 

MedStar Health is seeking people who have tested positive for COVID-19 and are fully recovered.  Patients who have recovered from COVID-19 infection may be able to donate plasma as a potential therapy for patients with serious COVID-19 infections.

Plasma, the liquid portion of the blood, contains blood proteins (antibodies) that can attack the virus.  MedStar Health will be conducting a research project using plasma as a treatment for patients who are seriously ill from COVID-19.

If you have had a COVID-19 positive test and have fully recovered and if you are interested in participating or would like to know more about this study, please call 202-877-6290.

Research Activities During COVID-19

The Office of Research Integrity has been actively supporting research teams regarding the possible need for changes to research activities during COVID-19.

MedStar Health Research Institute has been working with MedStar Health Corporate Compliance and the Georgetown HRPP team to develop joint guidance for the MedStar Health Research Institute, Georgetown University Medical Center, and Georgetown University Main Campus.

This guidance will require revision as conditions change. We will keep you informed of any updates to this guidance as they are available. 

As always, if you have any questions or concerns with this guidance, please contact ORI for clarification or additional guidance.

MHRI Office of Research Integrity
301-560-2912
[email protected]
Jim Boscoe
Director, Office of Research Integrity, MHRI
[email protected]
301-821-1530

Guidance for COVID-19’s Possible Effects on Research Involving Human Subjects (updated March 19, 2020)

In light of the unfolding COVID-19 pandemic, and in order to sustain our research activities as efficiently as possible, the following guidelines are issued jointly by the Medstar Health Research Institute, and the Georgetown University Medical Center and Main Campus, for the benefit of investigators and associated staff in both institutions. Specific questions relating to IRB practices and procedures should be directed to your home institution's IRB office.

The guidance/FAQ document can be viewed here.

 

Guidance for COVID-19 and Emergency Use (updated March 19, 2020)

We have a patient who tested positive for COVID-19 and want to pursue an Emergency Use of a Test Article. What do we do?  The guidance/FAQ document can be viewed here.

Raj Ratwani Appointed to Newly Created Vice President of Scientific Affairs Position

As part of our continued progress toward becoming a world-class academic health system, and advancing health through research and innovation, we are pleased to announce the appointment of Raj Ratwani, PhD, as Vice President of Scientific Affairs for MedStar Health Research Institute (MHRI). In this new position for MedStar, Raj will play a pivotal role in connecting the scientific activities of MHRI, MedStar Institute for Innovation (MI2), and the MedStar Institute for Quality and Safety (MIQS). He will join the MHRI executive leadership team to provide additional scientific perspectives that support research activities and their interaction with clinical operations.

In his new role on the MHRI executive team, Dr. Ratwani will contribute to the strategy, growth, and administration of research across MedStar, with a focus on working closely with organizational leaders and investigators to translate research results into practice. He will supervise and mentor investigators to support research activities, identify new areas of research funding and enhance MHRI’s reputation as a leading research organization. Furthermore, Dr. Ratwani will lead strategy development for MHRI to support the effective dissemination of research outputs. Dr. Ratwani will remain director of the MedStar Health National Center for Human Factors in Healthcare.

Please join us in congratulating Dr. Ratwani on his promotion as we continue to advance health for our patients and community.





Diabetes to Go

Diabetes to Go

Overview

Diabetes self-management education and support (DSMES) is key to reducing the burden of diabetes both on those living with this chronic, complex condition and on the healthcare system.1 DSMES is defined as the ongoing process of facilitating the knowledge, skills, and ability necessary for diabetes self-care.2–4 Effective delivery and patient uptake of DSMES has been shown to improve outcomes, including reduction in hemoglobin A1C, diabetes-related complications 5,6 and acute care encounters,7 and to promote adoption of healthy lifestyle behaviors.3,8–10

Research confirms that DSMES is largely underutilized. For example, less than 5% of Medicare beneficiaries access their DSMES benefits,11 and as few as 7% of patients with private insurance receive DSMES within the one-year after diabetes diagnosis.12 Innovative approaches for reaching patients with T2DM and successfully engaging them in DSMES are required to optimize its potential impact.

Diabetes survival skills education (DSSE), a component of DSMES, is the process of facilitating the core knowledge, skills, and ability necessary for safe and effective diabetes self-care in the short term.14–16 The goal of DSSE is to keep patients safe and stable during transitions of care (e.g., from hospital to home) and for patients with T2DM to be able to recognize when their diabetes is not well managed (e.g., hypo or hyperglycemic events).

Approaches to effectively deliver standardized self-care management education and support for adults living with Type 2 diabetes (T2DM) are needed to enable optimal outcomes.

Diabetes To Go is the education program of the MedStar Diabetes Institute.

This program has been developed by our diabetes specialists, including Endocrinologists and nurses, nutritionists, nurse practitioners and pharmacist who are diabetes educators, in partnership with our Primary Care Physicians. Our patients and a health literacy specialist helped develop and reviewed the program.

The Diabetes To Go Booklet covers diabetes survival skills – or the basics about diabetes.

The Diabetes To Go Pocket Guide is a brief summary of the same content that is found in the booklet.

The Diabetes To Go program has a full set of companion videos.  A few samples of these videos are found below for viewing.

 


For Patients

Know About Your Diabetes: Full Guide

Survival Skills Basics Pocket Guide

 


Diabetes to Go Sample Videos

 

Application Process: Logic Chart for Video Playlists

 


For Staff & Clincians

Process Chart for Education Delivery

Tablet Cleaning Job Aid

Create a Patient Account

Script: Invite a Patient to Join in Education

Survival Skills Basics Pocket Guide

 


MedStar Diabetes and Research Institutes’ “Diabetes To Go-Inpatient Study” was funded by the National Institutes of Health-NIDDK R34 DK-105903 Award. This grant funded redesign of the MDI’s Diabetes To Go education materials .


References

  1. Powers MA, Bardsley J, Cypress M, et al. Diabetes Self-management Education and Support in Type 2 Diabetes. Diabetes Educ. 2017;43(1):40-53. doi:10.1177/0145721716689694
  2. Armstrong C. ADA Updates Standards of Medical Care for Patients with Diabetes Mellitus. Am Fam Physician. 2017;95(1):40-43. http://www.ncbi.nlm.nih.gov/pubmed/28075100. Accessed May 5, 2017.
  3. Powers MA, Bardsley J, Cypress M, et al. Diabetes Self-Management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. J Acad Nutr Diet. 2015;115(8):1323-1334. doi:10.1016/j.jand.2015.05.012
  4. Beck J, Greenwood DA, Blanton L, et al. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Educ. 2017;43(10):1409-1419. doi:10.2337/dci17-0025
  5. Steinsbekk A, Rygg L, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res. 2012;12(1):213. doi:10.1186/1472-6963-12-213
  6. Rise MB, Pellerud A, Rygg LØ, Steinsbekk A. Making and Maintaining Lifestyle Changes after Participating in Group Based Type 2 Diabetes Self- Management Educations: A Qualitative Study. PLoS One. 2013;8(5):e64009. doi:10.1371/journal.pone.0064009
  7. Healy SJ, Black D, Harris C, Lorenz A, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patientswith poor glycemic control. Diabetes Care. 2013;36(10):2960-2967. doi:10.2337/dc13-0108
  8. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99:926-943. doi:10.1016/j.pec.2015.11.003
  9. Magee M, Bowling A, Copeland J, Fokar A, Pasquale P, Youssef G. The ABCs of diabetes: diabetes self-management education program for African Americans affects A1C, lipid-lowering agent prescriptions, and emergency department visits. Diabetes Educ. 37(1):95-103. doi:10.1177/0145721710392246
  10. Gurková E, Čáp J, Žiaková K. Quality of life and treatment satisfaction in the context of diabetes self-management education. Int J Nurs Pract. 2009;15(2):91-98. doi:10.1111/j.1440-172X.2009.01733.x
  11. Strawbridge LM, Lloyd JT, Meadow A, Riley GF, Howell BL. One-Year Outcomes of Diabetes Self-Management Training Among Medicare Beneficiaries Newly Diagnosed With Diabetes. Med Care. 2017;55(4):391-397. doi:10.1097/MLR.0000000000000653
  12. Li R, Shrestha SS, Lipman R, et al. Diabetes self-management education and training among privately insured persons with newly diagnosed diabetes--United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014;63(46):1045-1049. http://www.ncbi.nlm.nih.gov/pubmed/25412060. Accessed July 8, 2019.
  13. Ferguson S, Swan M, Smaldone A. Does Diabetes Self-management Education in Conjunction With Primary Care Improve Glycemic Control in Hispanic Patients? Diabetes Educ. 2015;41(4):472-484. doi:10.1177/0145721715584404
  14. Hardee SG, Osborne KC, Njuguna N, et al. Interdisciplinary diabetes care: A new model for inpatient diabetes education. Diabetes Spectr. 2015;28(4):276-282. doi:10.2337/diaspect.28.4.276
  15. Youssef G, Ip EH, Magee M, et al. Validity and Reliability of a (Brief) Diabetes “Survival Skills” Knowledge Test: KNOW Diabetes. Diabetes Educ. 2019;45(2):184-193. doi:10.1177/0145721719828064
  16. Lewis VR, Benda N, Nassar C, Magee MF. Successful Patient Diabetes Education in the Emergency Department. Diabetes Educ. 2015;41(3):343-350. doi:10.1177/0145721715577484

 

 

 

 

 

 

ObEN Creates Healthcare Avatar for MedStar Health Heart Disease Study

 

Personal AI of nurse to aid in at-home monitoring of patients suffering from heart failure

Pasadena, CA/Hyattsville, MD (March 4, 2019) — ObEN Inc., the artificial intelligence (AI) company creating Personal AI (PAI) technology to revolutionize digital interactions, is pleased to announce it is working with MedStar Health Research Institute for a study on the use of Personal AI (PAI) healthcare assistants for patients suffering from heart failure. For the study, ObEN has created a medical health assistant app, called PAI Care, to help monitor patients of heart failure.

Under the direction of the principal investigator Nawar Shara, PhD, Director of the Department of Biostatistics and Biomedical Informatics at MedStar Health Research Institute and Associate Professor of Medicine at Georgetown University, the study will investigate the use of voice-activated and avatar-enabled technologies for monitoring heart failure patients at home and whether this monitoring improves health and recovery outcomes. The study will include patients interacting with Tara, an intelligent 3D Healthcare Assistant Avatar created using ObEN’s PAI technology, via an app on a tablet.

“Heart failure is a chronic, progressive condition that impacts millions of people worldwide and is increasing in incidence,”said Dr. Shara. “Hospitalization is a major driver of treatment costs and adversely affects the quality of life and outcomes for heart failure patients. Prevention of heart failure hospital readmission is an area of unmet need. This study leverages voice and avatar-enabled artificial intelligence technologies to empower patients to better manage their condition.”

For this four-month study, ObEN’s technology will fuel the voice, appearance, and animation of the healthcare assistant avatar in PAI Care as well as the chatbot feature through which the patients can interact with the PAI. Under a daily schedule, participants in the study will answer a series of health and wellness questions that will help the study collect data and also monitor the health of the patients.

ObEN is also providing additional technology for a related-study by MedStar Health Research Institute, using voice-enabled healthcare support. This study is made possible with grant funding from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) through the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS).

“ObEN’s technology can potentially create a way to provide triage, management, and routine health reminders while alleviating pain points within the healthcare industry including patient monitoring, EHS systems management, and geriatric care and companionship,” said Nikhil Jain, CEO of ObEN. “With the healthcare industry facing rising costs, insufficient resources and a lack of manpower around the world, we believe PAI can serve as the basis for solutions to the most pressing issues in healthcare and provide better access to service for all people.”

Using ObEN’s proprietary full-stack AI technology, ObEN can create personalized, intelligent 3D avatars that look and sound like the user, can learn to behave like the user, and even learn skills the user does not possess, like speaking in multiple languages. ObEN has also adopted the Project PAI blockchain protocol, an open source decentralized public utility blockchain, to secure and authenticate the PAIs and the associated user data, allowing people to gain more ownership of their own digital identity. For healthcare applications, ObEN enables the creation of Nurse and Doctor PAIs that can be individualized to the real professionals providing care to their patients.

To learn more about Personal AI technology visit oben.com


About ObEN
ObEN is an artificial intelligence (AI) company developing Personal AI technology that revolutionizes personal digital interaction, enabling never before possible social and virtual interactions. The company’s technology allows users to create intelligent 3D avatars that look, sound, and behave like them. Deployed on the Project PAI blockchain, ObEN’s Personal AI (PAI) technology enables users to create, use, and manage their own PAI on a secure, decentralized platform. Founded in 2014, ObEN is a K11, Tencent, Softbank Ventures Korea and HTC Vive X portfolio company and is located at Idealab in Pasadena, California. To learn more about ObEN, please visit oben.com.

About MedStar Health Research Institute
MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative, and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis, and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. For more information, visit MedStarResearch.org.

About MedStar Health
MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region while advancing the practice of medicine through education, innovation, and research. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion, and clinical excellence with an emphasis on customer service. For more information, visit MedStarHealth.org.

Newsroom

Click below to go to our Newsroom.

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

Lisa Wang
Senior Marketing Manager, ObEN
[email protected]